Physician profile
Stephen Ray
NPI 1265419188
$2,305.29
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,367 · 2020: $734 · 2022: $35.75 · 2024: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $1,694.67 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $116.51 | 2024 | |
| Amgen INC. | $108.92 | 2019-2020 | |
| Pfizer INC. | $75.47 | 2019 | |
| Celgene Corporation | $56.57 | 2019 | |
| Astellas Pharma US INC | $50.08 | 2019-2020 | |
| Eisai INC. | $47.27 | 2020-2024 | |
| Taiho Oncology, INC. | $44.79 | 2019 | |
| Leica Microsystems INC. | $35.75 | 2022 | |
| Emd Serono, INC. | $27.84 | 2024 | |
| Kyowa Kirin, INC. | $18.95 | 2019 | |
| Allergan, INC. | $16.23 | 2019 | |
| Tactile Systems Technology INC | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.